Pennant Investors »

Macrogenics shares owned by Pennant Investors

Quarter-by-quarter ownership of Macrogenics (MGNX) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Macrogenics

Tip: Access up to 7 years of quarterly data

All positions including Macrogenics held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Macrogenics by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $645k 44k 14.72

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Macrogenics

Bellevue Group
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Frazier Life Sciences Management
T. Rowe Price Associates
Armistice Capital
RA Capital Management
Geode Capital Management
Rock Springs Capital Management
Dimensional Fund Advisors
Jpmorgan Chase & Co
Daniel D. Thurber
Ikarian Capital
Federated Investors

View all funds holding Macrogenics